Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05323149
PHASE3

Tranexamic Acid in Traumatic Brain Injury

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).

Official title: The Impact of Early Use of Tranexamic Acid in Traumatic Brain Injury Upon the Inflammatory Response and Outcome

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2022-05-18

Completion Date

2027-10-15

Last Updated

2026-01-02

Healthy Volunteers

No

Interventions

OTHER

Saline

Giving saline (loading dose of 1gm of saline 0.9%, followed by a 1gm of maintenance saline dose over 8 hours for 48 h).

DRUG

Tranexamic acid

Giving TXA (loading dose of 1gm of TXA, followed by a 1gm of maintenance dose over 8 hours for 48 h).

Locations (1)

Assiut university hospital

Asyut, Assuit, Egypt